From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

New and Established Troponin Assays Are Highly Sensitive and Specific for AMI

Use of either type of assay can safely exclude or confirm AMI within 3 hours of emergency department admission.

Early recognition or exclusion of acute myocardial infarction (AMI) is critical for determining which patients do or do not require additional diagnostic and therapeutic measures. In a prospective study, researchers compared the accuracy of a novel highly sensitive troponin I (hsTnI) assay (Architect STAT High Sensitivity Troponin; Abbott Diagnostics) and an established troponin I (eTnI) assay (Architect STAT) for diagnosing AMI at admission and at 3 hours. The study was partially funded by the manufacturer of the assays.

Of 1818 consecutive patients with suspected acute coronary syndrome who were enrolled at three hospitals in Germany during 2007 and 2008, 413 patients (23%) received a diagnosis of AMI; 56 patients with AMI (14%) presented with ST-segment-elevation. Using a diagnostic cutoff troponin concentration representing the 99th percentile of a reference population, hsTnI at admission had a sensitivity of 82% and a negative predictive value (NPV) of 95% for AMI, and eTnI had a sensitivity of 79% and an NPV of 94%. Sensitivity and NPV at 3 hours for both assays were 98% and 99%, respectively. Combining the measurement at admission with the relative change at 3 hours yielded positive predictive values of 96% for both assays.

Comment: These data indicate that, for patients with suspected acute coronary syndrome, results of either troponin I assay 3 hours after emergency department admission can be used to rule out AMI with 99% accuracy, and the relative change in assay results from admission to 3 hours can be used to identify patients with high likelihood of AMI who need immediate invasive diagnostic and therapeutic procedures. This is exciting news.

John A. Marx, MD, FAAEM

Published in Journal Watch Emergency Medicine January 20, 2012

Citation(s):

Keller T et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011 Dec 28; 306:2684.

Reader Remarks:

Review and add to remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2012. Massachusetts Medical Society. All rights reserved.